MAPT and diabetes mellitus: That was subsequently confirmed by a study that indicated an increase in the rate of functional activity decline among patients with both diabetes and one of the AD risk variables, either genetic susceptibility, such as carrying the ApoE E4 allele, or CSF alterations of total tau and p-tau, but not CSF Aβ [131].